See also this year's filing and all EDGAR filings for this company.
PDF Report 0001796129_2022_Vincerx_Pharma_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001796129, Vincerx Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 111,841,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 233,000 |
| 3 | remainder_Assets | 5,602,000 |
| 4 | LiabilitiesCurrent | 13,919,000 |
| 5 | LiabilitiesNoncurrent | 3,436,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 22,575,000 |
| 9 | ResearchAndDevelopmentExpense | 40,081,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 23,350,000 |
| 13 | remainder_ComprehensiveNetIncome | -21,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 117,676,000 |
| 1 | Liabilities | 17,355,000 |
| 2 | Expenses | 62,656,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 100,321,000 |
| 5 | NetIncome | -39,306,000 |
| 6 | ComprehensiveNetIncome | -39,316,500 |
| 7 | BaseVar | 110,529,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.66 |
| 9 | EconomicCapitalRatio | 3.46 |
Edgar->Model Mapping
Feature Distribution
Change over Time
